Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

NCT00103051 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: gefitinib
DRUG: gemcitabine hydrochloride
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC